Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 3 | 2023 | 161 | 1.110 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 413 | 0.910 |
Why?
|
| Chronic Pain | 1 | 2023 | 145 | 0.770 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2008 | 137 | 0.680 |
Why?
|
| Physicians | 3 | 2023 | 673 | 0.670 |
Why?
|
| Vasospasm, Intracranial | 4 | 2008 | 36 | 0.660 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 582 | 0.620 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 77 | 0.530 |
Why?
|
| Women's Health | 1 | 2016 | 100 | 0.520 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 41 | 0.510 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 112 | 0.470 |
Why?
|
| Primary Health Care | 1 | 2016 | 339 | 0.430 |
Why?
|
| Hypertension, Pulmonary | 1 | 2016 | 346 | 0.430 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 521 | 0.400 |
Why?
|
| Mass Screening | 1 | 2015 | 618 | 0.370 |
Why?
|
| Obesity | 1 | 2016 | 963 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 827 | 0.330 |
Why?
|
| Hypertension | 1 | 2016 | 1141 | 0.300 |
Why?
|
| Stroke | 1 | 2015 | 965 | 0.270 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 119 | 0.260 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 429 | 0.240 |
Why?
|
| Pain | 2 | 2023 | 391 | 0.240 |
Why?
|
| United States | 5 | 2023 | 6672 | 0.220 |
Why?
|
| Buprenorphine | 1 | 2023 | 33 | 0.220 |
Why?
|
| Medicare | 2 | 2023 | 410 | 0.220 |
Why?
|
| Outpatients | 1 | 2022 | 94 | 0.210 |
Why?
|
| Aftercare | 1 | 2023 | 85 | 0.210 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 141 | 0.210 |
Why?
|
| Continuity of Patient Care | 1 | 2023 | 169 | 0.200 |
Why?
|
| Inpatients | 1 | 2023 | 297 | 0.180 |
Why?
|
| Basilar Artery | 3 | 2008 | 41 | 0.170 |
Why?
|
| Humans | 12 | 2023 | 86643 | 0.170 |
Why?
|
| Hospitalization | 1 | 2023 | 849 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 231 | 0.150 |
Why?
|
| Hepatitis C | 1 | 2018 | 208 | 0.140 |
Why?
|
| Potassium | 2 | 2008 | 281 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2018 | 510 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 806 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2016 | 478 | 0.120 |
Why?
|
| Cerebral Angiography | 3 | 2008 | 196 | 0.100 |
Why?
|
| Dogs | 3 | 2008 | 685 | 0.100 |
Why?
|
| Patch-Clamp Techniques | 3 | 2008 | 396 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1851 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1036 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2018 | 1004 | 0.090 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 11 | 0.080 |
Why?
|
| Membrane Potentials | 2 | 2008 | 435 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2008 | 93 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 132 | 0.080 |
Why?
|
| MEDLINE | 1 | 2006 | 8 | 0.070 |
Why?
|
| Review Literature as Topic | 1 | 2006 | 21 | 0.070 |
Why?
|
| Peptides, Cyclic | 1 | 2006 | 43 | 0.070 |
Why?
|
| Barium | 1 | 2006 | 31 | 0.070 |
Why?
|
| Magnesium | 1 | 2006 | 177 | 0.070 |
Why?
|
| Potassium Channels | 1 | 2008 | 340 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 135 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 2232 | 0.070 |
Why?
|
| Risk Factors | 1 | 2016 | 5417 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8489 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 354 | 0.060 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2023 | 5 | 0.060 |
Why?
|
| Opiate Substitution Treatment | 1 | 2023 | 30 | 0.060 |
Why?
|
| Naloxone | 1 | 2023 | 59 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 865 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 378 | 0.050 |
Why?
|
| Fee-for-Service Plans | 1 | 2022 | 30 | 0.050 |
Why?
|
| Female | 3 | 2023 | 44532 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 102 | 0.050 |
Why?
|
| Time Factors | 2 | 2008 | 5210 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 1143 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2023 | 300 | 0.050 |
Why?
|
| Critical Care | 1 | 2023 | 370 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1981 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2023 | 2767 | 0.040 |
Why?
|
| Aged | 2 | 2023 | 18415 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 539 | 0.030 |
Why?
|
| Animals | 3 | 2008 | 26582 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2008 | 144 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 188 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 98 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 332 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2008 | 347 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 1513 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2818 | 0.010 |
Why?
|
| Male | 1 | 2023 | 40965 | 0.010 |
Why?
|